Stock Research for CVT

Featured Broker: Ally Invest

Get the due diligence for another stock.


CVT Stock Chart & Research Data

The CVT chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CVT chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


CVT Due diligence Resources & Stock Charts

The CVT stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CVT Detailed Price Forecast - CNN Money CNN View CVT Detailed Summary - Google Finance
Yahoo View CVT Detailed Summary - Yahoo! Finance Zacks View CVT Stock Research & Analysis -

Stock Analysis

TradeIdeas View CVT Trends & Analysis - Trade-Ideas Barrons View CVT Major Holders - Barrons
NASDAQ View CVT Call Transcripts - NASDAQ Seeking View CVT Breaking News & Analysis - Seeking Alpha
Spotlight View CVT Annual Report - OTC Report View CVT OTC Short Report -
TradeKing View CVT Fundamentals - TradeKing Charts View CVT SEC Filings - Bar Chart
WSJ View Historical Prices for CVT - The WSJ Morningstar View Performance/Total Return for CVT - Morningstar
MarketWatch View the Analyst Estimates for CVT - MarketWatch CNBC View the Earnings History for CVT - CNBC
StockMarketWatch View the CVT Earnings - StockMarketWatch MacroAxis View CVT Buy or Sell Recommendations - MacroAxis
Bullish View the CVT Bullish Patterns - American Bulls Short Pains View CVT Short Pain Metrics -

Social Media Mentions

StockTwits View CVT Stock Mentions - StockTwits PennyStocks View CVT Stock Mentions - PennyStockTweets
Twitter View CVT Stock Mentions - Twitter Invest Hub View CVT Investment Forum News - Investor Hub
Yahoo View CVT Stock Mentions - Yahoo! Message Board Seeking Alpha View CVT Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for CVT - Insider Cow View Insider Transactions for CVT - Insider Cow
CNBC View CVT Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CVT - OTC Markets
Yahoo View Insider Transactions for CVT - Yahoo! Finance NASDAQ View Institutional Holdings for CVT - NASDAQ

Stock Charts

FinViz View CVT Stock Insight & Charts - StockCharts View CVT Investment Charts -
BarChart View CVT Stock Overview & Charts - BarChart Trading View View CVT User Generated Charts - Trading View

Latest Financial News for CVT

Cvent, Inc. -- Moody's affirms Cvent CFR and Sr Sec at B3; outlook revised to stable from positive
Posted on Thursday October 18, 2018

Moody's Investors Service ("Moody's") affirmed Cvent Inc.'s ("Cvent") Corporate Family rating ("CFR") at B3, Probability of Default rating ("PDR") at B3-PD and senior secured first lien revolver and term loan at B3. The rating outlook was revised to stable from positive. On Tuesday, Cvent announced it had acquired Social Tables, Inc. ("Social Tables") in a debt-financed transaction funded in part by a $53 million increase in its senior secured 1st lien term loan, bringing the total outstanding amount to approximately $750 million.

Two Chinese firms bid for NZ honey maker Manuka Health - source
Posted on Sunday July 29, 2018

* First-round bids arrive from China - source * Intense Chinese interest in NZ produce * No comments from Manuka Health or PE owner (Adds deal timing, detail of Chinese investment in Australia, honey background) ...

Deals of the day-Mergers and acquisitions
Posted on Monday April 16, 2018

The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Monday: ** Shire, the London-listed rare diseases specialist that is a potential takeover target for Japan's Takeda Pharmaceutical, is selling its oncology business to unlisted French drugmaker Servier for $2.4 billion. ** Pebblebrook Hotel Trust has sweetened its $3 billion-plus offer to buy U.S. peer LaSalle Hotel Properties after the owner of high-end locations including 'W' Los Angeles saw an initial bid rebuffed last month.

Posted on Wednesday December 31, 1969

Stock Market & Investing Books

Enter a stock symbol to view the stock details.